Albayrak A - Search Results

1

Assessment of polypharmacy, potentially inappropriate medications, and drug-drug interactions in older patients with cancer.

Albayrak A, Erbay B, Kayıkçıoğlu E. Albayrak A, et al. J Oncol Pharm Pract. 2024 May 16:10781552241255140. doi: 10.1177/10781552241255140. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 38751371

2

Potential drug-drug interactions in patients with non-small cell lung cancer at a university hospital in Turkey.

Albayrak A, Düzenli T, Kayıkçıoğlu E. Albayrak A, et al. J Cancer Res Clin Oncol. 2023 Sep;149(12):9621-9627. doi: 10.1007/s00432-023-04890-0. Epub 2023 May 24. J Cancer Res Clin Oncol. 2023. PMID: 37222813

3

Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey.

Albayrak A, Demirbaş H. Albayrak A, et al. BMC Geriatr. 2023 Oct 13;23(1):655. doi: 10.1186/s12877-023-04381-4. BMC Geriatr. 2023. PMID: 37833671 Free PMC article.

4

Assessment of breast cancer awareness among female pharmacy students at a university in Turkey.

Albayrak A, Cengiz KN. Albayrak A, et al. BMC Med Educ. 2024 Apr 3;24(1):363. doi: 10.1186/s12909-024-05353-x. BMC Med Educ. 2024. PMID: 38570769 Free PMC article.

5

Determination of drug-related problems in the hematology service: a prospective interventional study.

Albayrak A, Özbalcı D. Albayrak A, et al. BMC Cancer. 2024 May 2;24(1):552. doi: 10.1186/s12885-024-12291-w. BMC Cancer. 2024. PMID: 38698336 Free PMC article.

6

The impact of antimicrobial use on potential major drug-drug interactions in the pediatric Intensive Care Unit patients at University Hospital in Türkiye.

Albayrak A, Akkuzu E, Karahalil B. Albayrak A, et al. Minerva Pediatr (Torino). 2024 Jun;76(3):388-394. doi: 10.23736/S2724-5276.21.06173-9. Epub 2021 Apr 15. Minerva Pediatr (Torino). 2024. PMID: 33858128

7

Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.

Albayrak A, Başgut B, Bıkmaz GA, Karahalil B. Albayrak A, et al. BMC Health Serv Res. 2022 Jan 15;22(1):79. doi: 10.1186/s12913-022-07494-5. BMC Health Serv Res. 2022. PMID: 35033079 Free PMC article.

8

Impact of clinical pharmacist's interventions on clinical outcomes in appropriate use of colistin: a prospective pre-post intervention study.

Albayrak A, Özger HS, Başgut B, Aygencel Bıkmaz G, Karahalil B. Albayrak A, et al. J Chemother. 2023 Dec;35(8):712-720. doi: 10.1080/1120009X.2023.2196916. Epub 2023 Apr 6. J Chemother. 2023. PMID: 37021512

9

Meropenem, rifampicin and gentamicin combination therapy in a patient with complicated urinary tract infection caused by extreme drug-resistant P. aeruginosa.

Albayrak A, Fakioğlu DM, Şenol E. Albayrak A, et al. Eur J Hosp Pharm. 2020 Mar;27(2):121-122. doi: 10.1136/ejhpharm-2019-001873. Epub 2019 Jul 13. Eur J Hosp Pharm. 2020. PMID: 32133141 Free PMC article.

10

Evaluation of parental knowledge, attitudes and practices regarding antibiotic use in acute upper respiratory tract infections in children under 18 years of age: a cross-sectional study in Turkey.

Albayrak A, Karakaş NM, Karahalil B. Albayrak A, et al. BMC Pediatr. 2021 Dec 6;21(1):554. doi: 10.1186/s12887-021-03020-4. BMC Pediatr. 2021. PMID: 34872522 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters